Dr. Max Gouverne, MD Cosmetic Surgery is categorized under Plastic Surgeons in Corpus Christi, TX .
Dr. Max Gouverne, MD Cosmetic Surgery was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Plastic Surgeons business, which does work in the B2C market, and is classified as a Plastic Surgeons, under code number 0 by the NAICS.
If you are seeking more information, feel free to contact Max Gouverne, at the company’s single location by writing to 5642 Esplanade Dr, Corpus Christi, Texas TX 78414 or by phoning (361) 993-2222. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Dr. Max Gouverne, MD Cosmetic Surgery |
Contact Person: | Max Gouverne, |
Address: | 5642 Esplanade Dr, Corpus Christi, Texas 78414 |
Phone Number: | (361) 993-2222 |
Website Address: | bringoutyourbest.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Plastic Surgeons |
SIC Code: | 0 |
NAICS Code: | 0 |
Share This Business: |
Dr. Max Gouverne, MD Cosmetic Surgery was started in 0 to provide professional Plastic Surgeons under the SIC code 0 and NAICS code 0. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Max Gouverne, for inquiries that concern Dr. Max Gouverne, MD Cosmetic Surgery by calling the company number (361) 993-2222, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr. Max Gouverne, MD Cosmetic Surgery can be found at the coordinates 27.689254,-97.379539000 as well as the street address 5642 Esplanade Dr in Corpus Christi, Texas 78414.
For its online presence, you may visit Dr. Max Gouverne, MD Cosmetic Surgery’s website at bringoutyourbest.com and engage with its social media outlets through on Twitter and on Facebook.